Abstract
In early recurrent herpetic lesions, CD4 T lymphocytes are the predominant infiltrating cells, and keratinocytes expressing major histocompatibility complex (MHC) class II antigens, induced by interferon-gamma (IFN-gamma), are the major site of herpes simplex virus (HSV) replication. IFN-gamma pretreatment of human keratinocytes in vitro reduced MHC class I antigen down-regulation by HSV-1 infection and induced expression of HLA-DR that was unaltered by subsequent HSV-1 infection. Incubation of these infected keratinocytes with phosphonoacetic acid (PAA) almost completely inhibited expression of four major HSV glycoproteins, although expression of early proteins was not affected. Weak CD8 T lymphocyte cytotoxicity against IFN-gamma-stimulated, HLA-DR-expressing HSV-1-infected keratinocytes was consistently directed to the immediate early/early proteins (all 9 patients tested) but against late proteins to a lesser degree (4/9 patients). However, CD4 T lymphocyte cytotoxicity was much greater and directed predominantly against late HSV-1 glycoproteins (all 9 subjects tested) in these cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antiviral Agents / pharmacology*
-
CD4-Positive T-Lymphocytes / immunology*
-
CD8-Positive T-Lymphocytes / immunology*
-
Cells, Cultured
-
Cytotoxicity, Immunologic
-
Down-Regulation
-
Fibroblasts / drug effects
-
Fibroblasts / immunology
-
Fibroblasts / virology
-
Flow Cytometry
-
Herpesvirus 1, Human / physiology*
-
Histocompatibility Antigens Class I / biosynthesis
-
Histocompatibility Antigens Class II / biosynthesis
-
Humans
-
Immediate-Early Proteins / biosynthesis
-
Interferon-gamma / pharmacology*
-
Keratinocytes / drug effects
-
Keratinocytes / immunology*
-
Keratinocytes / virology
-
Killer Cells, Natural / immunology
-
Phosphonoacetic Acid / pharmacology
-
Recombinant Proteins
-
Reverse Transcriptase Inhibitors / pharmacology
-
Skin / cytology
-
T-Lymphocytes, Cytotoxic / metabolism
-
Viral Envelope Proteins / biosynthesis
Substances
-
Antiviral Agents
-
Histocompatibility Antigens Class I
-
Histocompatibility Antigens Class II
-
Immediate-Early Proteins
-
Recombinant Proteins
-
Reverse Transcriptase Inhibitors
-
Viral Envelope Proteins
-
Interferon-gamma
-
Phosphonoacetic Acid